10-year results of NRG Oncology/NSABP B-42 trial

10-year results of NRG Oncology/NSABP B-42 trial

In the updated results from NRG Oncology/NSABP B-42 trial through 10 years of observation, extending letrozole therapy for additional five years after five years of adjuvant endocrine therapy resulted in a statistically significant improvement in the 10-year …

SAN ANTONIO, TX - In the updated results from NRG Oncology/NSABP B-42 trial through 10 years of observation, extending letrozole therapy for additional five years after five years of adjuvant endocrine therapy resulted in a statistically significant improveme… [+4235 chars]

Read full article | Read comments

0 comments

More health news